Pemetinib (pemetinib) indications, medication precautions
Pemetinib (pemetinib) is a targeted therapy drug that targets specific gene mutations. It is mainly used to treat patients with advanced, metastatic or unresectable cholangiocarcinoma with FGFR2 gene fusion or rearrangement. In addition, it also shows certain efficacy in relapsed or refractory myeloid or lymphoid tumors with FGFR1 rearrangements. The development of this innovative drug provides new hope for patients who have failed to respond to traditional treatments.
In terms of medication precautions, the first thing to emphasize is that pemetinib is a prescription drug and its use must be under the guidance of a doctor. Patients need to strictly follow the doctor's instructions and take the medicine according to the prescribed dosage and time. Generally speaking, the recommended dose of pemetinib is 13.5 mg per day, which should be taken orally once for 14 days and then stopped for 7 days to complete a 21-day treatment cycle.

While taking the medication, patients should maintain stable eating habits and avoid drinking alcohol, as alcohol may affect the metabolism and efficacy of the medication. Also, certain foods may interact with medications, so patients should follow their doctor's dietary recommendations. In addition, pemetinib tablets should be swallowed whole and avoid chewing, crushing or dissolving to ensure the best effect of the drug.
In terms of safety, although pemetinib may cause some side effects, such as diarrhea, nausea, fatigue, etc., these can be predicted and managed. The doctor will adjust the drug dosage or provide necessary supportive treatment according to the patient's specific condition. If any symptoms of discomfort occur, patients should contact their doctor immediately.
In general, pemetinib plays an important role in the treatment of malignant tumors such as cholangiocarcinoma due to its unique targeting and good tolerability. However, in order to ensure the best efficacy of the drug and patient safety, medication precautions and doctor's instructions must be strictly followed.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)